ATE228844T1 - Arzneimittel enthaltend lamotrigin - Google Patents

Arzneimittel enthaltend lamotrigin

Info

Publication number: ATE228844T1
Authority: AT; Austria
Prior art keywords: pct; products containing; medicinal products; lamotrigine; containing lamotrigine
Prior art date: 1995-06-23

Application number

AT96923914T

Other languages

English (en)

Inventor

Alison Green Floyd

Sunil Jain

Original Assignee

Wellcome Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-23

Filing date

1996-06-20

Publication date

2002-12-15

1996-06-20 Application filed by Wellcome Found filed Critical Wellcome Found

2002-12-15 Application granted granted Critical

2002-12-15 Publication of ATE228844T1 publication Critical patent/ATE228844T1/de

Links

PYZRQGJRPPTADH-UHFFFAOYSA-N lamotrigine Chemical compound NC1=NC(N)=NN=C1C1=CC=CC(Cl)=C1Cl PYZRQGJRPPTADH-UHFFFAOYSA-N 0.000 title abstract 2
229960001848 lamotrigine Drugs 0.000 title abstract 2
229940126601 medicinal product Drugs 0.000 title 1
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
239000012931 lyophilized formulation Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT96923914T 1995-06-23 1996-06-20 Arzneimittel enthaltend lamotrigin ATE228844T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9512854.2A GB9512854D0 (en)	1995-06-23	1995-06-23	Novel formulation
PCT/EP1996/002759 WO1997000681A1 (en)	1995-06-23	1996-06-20	Pharmaceutical composition containing lamotrigine

Publications (1)

Publication Number	Publication Date
ATE228844T1 true ATE228844T1 (de)	2002-12-15

Family

ID=10776584

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96923914T ATE228844T1 (de)	1995-06-23	1996-06-20	Arzneimittel enthaltend lamotrigin

Country Status (12)

Country	Link
US (1)	US5942510A (de)
EP (1)	EP0833640B1 (de)
JP (1)	JPH11507936A (de)
AT (1)	ATE228844T1 (de)
AU (1)	AU6415796A (de)
DE (1)	DE69625200T2 (de)
DK (1)	DK0833640T3 (de)
ES (1)	ES2188766T3 (de)
GB (1)	GB9512854D0 (de)
PT (1)	PT833640E (de)
SI (1)	SI0833640T1 (de)
WO (1)	WO1997000681A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9512854D0 (en) *	1995-06-23	1995-08-23	Wellcome Found	Novel formulation
GB9812413D0 (en) *	1998-06-10	1998-08-05	Glaxo Group Ltd	Compound and its use
DK1169060T3 (da) *	1999-04-09	2006-01-16	Euro Celtique Sa	Natriumkanalblokkerpræparater og anvendelse deraf
TWI233805B (en) *	1999-07-01	2005-06-11	Fujisawa Pharmaceutical Co	Stabilized pharmaceutical composition in lyophilized form as antifungal agent
IL157608A0 (en) *	2001-02-27	2004-03-28	Teva Pharma	New crystal forms of lamotrigine and processes for their preparations
DK1423168T3 (da) *	2001-09-03	2006-05-15	Newron Pharm Spa	Farmaceutisk præparat omfattende gabapentin eller en analog deraf og et alfa-aminoamid og dets analgetiske anvendelse
CA2483103A1 (en) *	2002-04-23	2003-11-06	Teva Pharmaceutical Industries Ltd.	Pharmaceutical composition containing lamotrigine particles of defined morphology
DE10327674A1 (de) *	2003-06-20	2005-01-05	Awd.Pharma Gmbh & Co. Kg	Injizierbare Darreichungsform von Flupirtin
DK1809271T5 (da) *	2004-09-10	2010-12-06	Newron Pharm Spa	Anvendelse af (R)-(halogenbenzyloxy)benzylaminopropanamider som natrium- og/eller calciumkanalselektive modulatorer
CA2615173C (en)	2005-07-14	2012-01-03	Lipothera, Inc.	Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
US20120142919A1 (en) *	2006-08-02	2012-06-07	Medichem, S.A.	Method for synthesizing lamotrigine
US8486927B2 (en) *	2007-11-09	2013-07-16	Thar Pharmaceuticals	Crystalline forms of lamotrigine
US9132084B2 (en)	2009-05-27	2015-09-15	Neothetics, Inc.	Methods for administration and formulations for the treatment of regional adipose tissue
GB2487868B (en) *	2010-01-15	2014-12-10	Neothetics Inc	Lyophilized cake formulations
UA111822C2 (uk)	2010-11-24	2016-06-24	Общєство С Огранічєнной Отвєтствєнностью "Новамедіка"	Монотерапевтичий препарат селективного ліпофільного бета-агоніста тривалої дії і спосіб косметичного лікування ожиріння і контурного випинання
CN104940128A (zh) *	2015-05-31	2015-09-30	黑龙江佰彤儿童药物研究有限公司	一种拉莫三嗪口服液体制剂及其制备方法
GB2641294A (en)	2024-05-24	2025-11-26	Novumgen Ltd	An orodispersible tablet of Lamotrigine and its process of preparation
US12605388B2 (en) *	2024-09-25	2026-04-21	Azurity Pharmaceuticals Ireland Limited	Lamotrigine salts, co-crystals, and compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK153787C (da) *	1979-06-01	1989-01-16	Wellcome Found	Analogifremgangsmaade til fremstilling af substituerede 3,5-diamino-6-phenyl-1,2,4-triaziner og alfa-cyanobenzyliden-aminoguanidinforbindelser til anvendelse som mellemprodukter herved
US4406888A (en) *	1981-01-09	1983-09-27	Pfizer Inc.	Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution
GB8613183D0 (en) *	1986-05-30	1986-07-02	Wellcome Found	Triazine salt
US5283067A (en) *	1987-01-30	1994-02-01	Ciba-Geigy Corporation	Parenteral suspensions
US5059619A (en) *	1989-06-14	1991-10-22	Quadra Logic Technologies, Inc.	Stable freeze-dried polyhematoporphyrin ether/ester
FR2699077B1 (fr) *	1992-12-16	1995-01-13	Rhone Poulenc Rorer Sa	Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
FR2702148B1 (fr) *	1993-03-05	1995-04-07	Rhone Poulenc Rorer Sa	Application d'anticonvulsivants dans le traitement du neuro-sida.
FR2702149B1 (fr) *	1993-06-03	1995-04-07	Rhone Poulenc Rorer Sa	Application de la lamotrigine dans le traitement du neuro-sida.
GB9317146D0 (en) *	1993-08-18	1993-10-06	Wellcome Found	Therapeutic combinations
JP3411038B2 (ja) *	1993-09-15	2003-05-26	シンテックス（ユー・エス・エイ）・インコーポレイテッド	ミコフェノール酸モフェチルの結晶質無水物およびその静注用製剤
GB9424766D0 (en) *	1994-12-07	1995-02-08	Wellcome Found	Pharmaceutical composition
GB9426448D0 (en) *	1994-12-30	1995-03-01	Wellcome Found	Process
GB9512854D0 (en) *	1995-06-23	1995-08-23	Wellcome Found	Novel formulation

1995
- 1995-06-23 GB GBGB9512854.2A patent/GB9512854D0/en active Pending
1996
- 1996-06-20 AT AT96923914T patent/ATE228844T1/de not_active IP Right Cessation
- 1996-06-20 DE DE69625200T patent/DE69625200T2/de not_active Expired - Fee Related
- 1996-06-20 AU AU64157/96A patent/AU6415796A/en not_active Abandoned
- 1996-06-20 WO PCT/EP1996/002759 patent/WO1997000681A1/en not_active Ceased
- 1996-06-20 DK DK96923914T patent/DK0833640T3/da active
- 1996-06-20 US US08/973,798 patent/US5942510A/en not_active Expired - Fee Related
- 1996-06-20 PT PT96923914T patent/PT833640E/pt unknown
- 1996-06-20 ES ES96923914T patent/ES2188766T3/es not_active Expired - Lifetime
- 1996-06-20 SI SI9630578T patent/SI0833640T1/xx unknown
- 1996-06-20 EP EP96923914A patent/EP0833640B1/de not_active Expired - Lifetime
- 1996-06-20 JP JP9503591A patent/JPH11507936A/ja active Pending

Also Published As

Publication number	Publication date
SI0833640T1 (en)	2003-08-31
PT833640E (pt)	2003-04-30
AU6415796A (en)	1997-01-22
EP0833640B1 (de)	2002-12-04
WO1997000681A1 (en)	1997-01-09
DE69625200D1 (de)	2003-01-16
JPH11507936A (ja)	1999-07-13
DE69625200T2 (de)	2003-08-21
DK0833640T3 (da)	2003-03-24
GB9512854D0 (en)	1995-08-23
ES2188766T3 (es)	2003-07-01
US5942510A (en)	1999-08-24
EP0833640A1 (de)	1998-04-08

Legal Events

Date

Code

Title

Description

2003-06-15

UEP

Publication of translation of european patent specification

Ref document number: 0833640

Country of ref document: EP

2010-03-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE228844T1 (de)	2002-12-15	Arzneimittel enthaltend lamotrigin
BG101118A (en)	1998-04-30	Therapeutical compounds
BR0215240A (pt)	2004-10-26	Derivados de calcona e seu uso no tratamento de doenças
DE69401204D1 (de)	1997-01-30	Gonadotropin enthaltende gefriergetrocknete troepfen
PT948527E (pt)	2002-11-29	Novos derivados de ciclosporina sua preparacao e composicoes farmaceuticas que os contem
BR9508655A (pt)	1997-08-12	Composição farmacêutica aquosa estéril
NO951198L (no)	1995-10-02	Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene
DE69525649D1 (de)	2002-04-04	Lamotrigin haltiges arzneimittel
BR9609847A (pt)	1999-03-09	Derivados de N-(4-Benzila-substituída)-2-aminolactam
ES2191099T3 (es)	2003-09-01	Derivados de hidantoina como productos intermedios para principios activos farmaceuticos.
SE9502219D0 (sv)	1995-06-19	Novel medical use
ES2132383T3 (es)	1999-08-16	Inhibidores de proteasa hiv.
DK0891341T3 (da)	2003-04-22	1,3,4-Oxadiazinderivater samt deres anvendelse som pesticider
BR9408244A (pt)	1997-05-27	Derivados de azabiciclo[3.2.0]heptano N-substituídos
MY121604A (en)	2006-02-28	Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc together with azt
ATE213410T1 (de)	2002-03-15	Diclofenac/gamma-cyclodextrin klathrat komponente
BG102404A (en)	1998-12-30	The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
BR9610175A (pt)	1998-08-11	Composto processo de preparação do composto composição farmacêutica e utilização do composto
PT989994E (pt)	2005-08-31	Derivados de estreptograminas, a sua preparacao e as composicoes que os contem
ES2095058T3 (es)	1997-02-01	Derivados del 3-azabiciclo(3.2.0)heptano substituidos como productos intermedios.
DK0805817T3 (da)	2001-11-26	Thiolderivater med metallopeptidaseinhiberende aktivitet
ATE198315T1 (de)	2001-01-15	Dimethyl-substituierte cyclohexandienderivate
KR960700053A (ko)	1996-01-19	방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)